Diagnosis and Management of Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Discuss the diagnosis, workup, and currently available agents for management of Waldenström’s macroglobulinemia
Steven P. Treon, MD, PhD
Dana-Farber/Brigham and Women's Cancer Center
- 0.25 Participation
- 0.33 Nurse
- 0.25 Pharmacist
- 0.25 Physician